Characterization of a single chain variable fragment of nivolumab that targets PD-1 and blocks PD-L1 binding-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of a single chain variable fragment of nivolumab that targets PD-1 and blocks PD-L1 binding

Published:2021-01 Issue: Volume:177 Page:105766
ISSN:1046-5928
Container-title:Protein Expression and Purification
language:en
Short-container-title:Protein Expression and Purification

Author:

Shin Jong^ORCID,Phelan Paul J.,Gjoerup Ole,Bachovchin William,Bullock Peter A.^ORCID

Funder

RepVir

Publisher

Elsevier BV

Subject

Biotechnology

Reference97 articles.

1. The future of immune checkpoint therapy;Sharma;Science,2015

2. PD-1 blockade induces responses by inhibiting adaptive immune resistance;Tumeh;Nature,2014

3. Immune checkpoint blockage: a common denominator approach to cancer therapy;Topalian;Canc. Cell,2015

4. Immune modulation in cancer with antibodies;Page;Annu. Rev. Med.,2014

5. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Canc.,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities;Frontiers in Medicine;2024-06-07

2. Evaluation of the cyclic single-chain Fv antibody derived from nivolumab by biophysical analyses and in vitro cell-based bioassay;The Journal of Biochemistry;2024-04-09

3. Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy;Cell Communication and Signaling;2024-01-25

4. Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1;mAbs;2023-08-02

5. Rational design of a Nivolumab-based ANTI-PD-1 single chain variable fragment that blocks the interaction between PD-1 expressed on T-CELLS and PD-L1 ON CHO cells;Protein Expression and Purification;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3